Whether you are a cannabis operator, lender, or investor, you have probably been hearing a lot of buzz about the potential ...

Congressional researchers are giving an update on the status of the federal-state marijuana law conflict, detailing the limitations of a pending rescheduling action, laying out options for lawmakers ...

Major marijuana companies owe the IRS significant back taxes, and pending marijuana rescheduling pushes won't change that, the agency argued.

On December 18, 2025, President Trump issued an executive order, “Increasing Medical Marijuana and Cannabidiol Research” directing the U.S. Attorney General to reclassify cannabis from a Schedule I ...

Forbes contributors publish independent expert analyses and insights. I cover the business of cannabis. For the U.S. legal cannabis industry, 2024 was a mixed bag. Progress was made on rescheduling ...

Federal marijuana rescheduling would represent a historic policy change with major implications for cannabis research and industry—but it should be viewed as a “transitional” step that must be ...

Retail investors in r/options are making an unusual bet on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), and the ...

This piece was published in in The Conversation on January 29, 2026. View the original article here. In December 2025, the Trump administration accelerated the process of reclassifying marijuana from ...

The proposed rescheduling of cannabis currently under consideration by the Department of Health and Human Services, the Department of Justice and the Drug Enforcement Agency would move it from ...

This video's transcript was generated by a third party. It is not curated or reviewed and is provided for convenience and information purposes only. The accuracy and completeness of the transcript are ...